Plus Therapeutics Gets Additional $1.9M Advance From CPRIT
Plus Therapeutics has received an additional $1.9 million advance from the Cancer Prevention and Research Institute of Texas, part...
AI Drug Discovery AstraZeneca BIO-Europe Spring 2026 biopharma M&A biopharma strategy biotech funding biotech strategy business development cancer immunotherapy China Biotech CNS Pipeline Strategy competitive intelligence Disease-Modifying Therapy Drug Pricing Strategy eClinical Tech News Eli Lilly Emerging Markets FDA Approval FDA Priority Review HER2 Oncology immuno-oncology immunology licensing deals Lifecycle Management Market Access Medtronic MSS colorectal cancer Novo Nordisk Obesity/GLP-1 Obesity Drug Market Obesity Market Oncology Pipeline Patent Cliff Priority Review Voucher pulmonary hypertension Rare Disease Regeneron respiratory biologics Roche Sanofi series A funding Teva Pharmaceuticals Type 1 Diabetes Type 2 Diabetes venture capital
No videos found.
Plus Therapeutics has received an additional $1.9 million advance from the Cancer Prevention and Research Institute of Texas, part...
Helio Diagnostics has launched as a Europe-based, end-to-end contract development and manufacturing partner focused exclusively on in vitro diagnostics....
Simcere has launched Quviviq (daridorexant) in mainland China for adult insomnia, with a notable regulatory distinction: the drug enters...
MediWound’s NexoBrid will take center stage at the European Burns Association Congress in Berlin this week, featured across 36...
Clearmind Medicine has arranged up to $10 million in convertible note financing with institutional investors, securing an initial $500,000...
NTA Implant, the dental implant brand of Switzerland-based Pilatus Swiss Dental GmbH, has secured European Union Medical Device Regulation...
Japan’s Ministry of Health, Labour and Welfare has approved Bylvay (odevixibat) for pruritus associated with progressive familial intrahepatic cholestasis...
Kraig Biocraft Laboratories plans to acquire an additional silkworm rearing center to expand production of its recombinant spider silk,...
Regeneron will donate up to 500 doses of Inmazeb, its FDA‑approved monoclonal antibody cocktail for infection caused by Orthoebolavirus...
Swissmedic has approved Jeraygo (aprocitentan) for resistant hypertension in adults, to be used alongside at least three antihypertensives, with...
